C
The Chemours Company
CC
$14.12
$0.130.93%
C
Hold
2/19/2025Upgraded
The Chemours Company (CC) was upgraded to C- from D+ on 2/19/2025 due to a large increase in the growth index, valuation index and total return index. Earnings per share increased from -$0.1804 to -$0.0597.
The Chemours Company (CC) was upgraded to C- from D+ on 2/19/2025 due to a large increase in the growth index, valuation index and total return index. Earnings per share increased from -$0.1804 to -$0.0597.
D
Sell
11/4/2024Downgrade
The Chemours Company (CC) was downgraded to D+ from C- on 11/4/2024 due to a significant decline in the growth index, valuation index and total return index. Earnings per share declined from $0.46 to -$0.1804, and total revenue declined 2.41% from $1.54B to $1.5B.
The Chemours Company (CC) was downgraded to D+ from C- on 11/4/2024 due to a significant decline in the growth index, valuation index and total return index. Earnings per share declined from $0.46 to -$0.1804, and total revenue declined 2.41% from $1.54B to $1.5B.
C
Hold
8/19/2024Downgrade
The Chemours Company (CC) was downgraded to C- from C on 8/19/2024 due to a decline in the total return index and volatility index.
The Chemours Company (CC) was downgraded to C- from C on 8/19/2024 due to a decline in the total return index and volatility index.
C
Hold
8/2/2024Upgraded
The Chemours Company (CC) was upgraded to C from D on 8/2/2024 due to a significant increase in the growth index, valuation index and efficiency index. Earnings per share increased from $0.34 to $0.46, net income increased 34.62% from $52M to $70M, and total revenue increased 13.93% from $1.35B to $1.54B.
The Chemours Company (CC) was upgraded to C from D on 8/2/2024 due to a significant increase in the growth index, valuation index and efficiency index. Earnings per share increased from $0.34 to $0.46, net income increased 34.62% from $52M to $70M, and total revenue increased 13.93% from $1.35B to $1.54B.
D
Sell
8/1/2024Downgrade
The Chemours Company (CC) was downgraded to D from D+ on 8/1/2024 due to a noticeable decline in the efficiency index, total return index and solvency index. The quick ratio declined from 0.73 to 0.69, and total capital declined 0.48% from $5.04B to $5.01B.
The Chemours Company (CC) was downgraded to D from D+ on 8/1/2024 due to a noticeable decline in the efficiency index, total return index and solvency index. The quick ratio declined from 0.73 to 0.69, and total capital declined 0.48% from $5.04B to $5.01B.
D
Sell
10/27/2023Downgrade
The Chemours Company (CC) was downgraded to D+ from C- on 10/27/2023 due to a decline in the volatility index, total return index and efficiency index.
The Chemours Company (CC) was downgraded to D+ from C- on 10/27/2023 due to a decline in the volatility index, total return index and efficiency index.
C
Hold
7/31/2023Downgrade
The Chemours Company (CC) was downgraded to C- from C+ on 7/31/2023 due to a significant decline in the valuation index, growth index and solvency index. Earnings per share declined from $0.96 to -$2.5219, EBIT declined 282.11% from $218M to -$397M, and debt to equity increased from 2.95 to 4.49.
The Chemours Company (CC) was downgraded to C- from C+ on 7/31/2023 due to a significant decline in the valuation index, growth index and solvency index. Earnings per share declined from $0.96 to -$2.5219, EBIT declined 282.11% from $218M to -$397M, and debt to equity increased from 2.95 to 4.49.
C
Hold
6/20/2023Downgrade
The Chemours Company (CC) was downgraded to C+ from B- on 6/20/2023 due to a decline in the total return index, valuation index and dividend index.
The Chemours Company (CC) was downgraded to C+ from B- on 6/20/2023 due to a decline in the total return index, valuation index and dividend index.
B
Buy
6/2/2023Upgraded
The Chemours Company (CC) was upgraded to B- from C+ on 6/2/2023 due to an increase in the total return index and volatility index.
The Chemours Company (CC) was upgraded to B- from C+ on 6/2/2023 due to an increase in the total return index and volatility index.
C
Hold
5/16/2023Downgrade
The Chemours Company (CC) was downgraded to C+ from B- on 5/16/2023 due to a decline in the total return index and valuation index.
The Chemours Company (CC) was downgraded to C+ from B- on 5/16/2023 due to a decline in the total return index and valuation index.
B
Buy
5/1/2023Upgraded
The Chemours Company (CC) was upgraded to B- from C on 5/1/2023 due to a significant increase in the growth index, solvency index and volatility index. EBIT increased 11,000% from -$2M to $218M, earnings per share increased from -$0.6467 to $0.96, and total revenue increased 14.8% from $1.34B to $1.54B.
The Chemours Company (CC) was upgraded to B- from C on 5/1/2023 due to a significant increase in the growth index, solvency index and volatility index. EBIT increased 11,000% from -$2M to $218M, earnings per share increased from -$0.6467 to $0.96, and total revenue increased 14.8% from $1.34B to $1.54B.
C
Hold
2/13/2023Downgrade
The Chemours Company (CC) was downgraded to C from B- on 2/13/2023 due to a significant decline in the growth index, valuation index and solvency index. Earnings per share declined from $1.52 to -$0.6467, EBIT declined 100.77% from $261M to -$2M, and operating cash flow declined 46.84% from $301M to $160M.
The Chemours Company (CC) was downgraded to C from B- on 2/13/2023 due to a significant decline in the growth index, valuation index and solvency index. Earnings per share declined from $1.52 to -$0.6467, EBIT declined 100.77% from $261M to -$2M, and operating cash flow declined 46.84% from $301M to $160M.
B
Buy
1/23/2023Upgraded
The Chemours Company (CC) was upgraded to B- from C+ on 1/23/2023 due to an increase in the total return index.
The Chemours Company (CC) was upgraded to B- from C+ on 1/23/2023 due to an increase in the total return index.
C
Hold
12/7/2022Downgrade
The Chemours Company (CC) was downgraded to C+ from B- on 12/7/2022 due to a major decline in the total return index and volatility index.
The Chemours Company (CC) was downgraded to C+ from B- on 12/7/2022 due to a major decline in the total return index and volatility index.
B
Buy
9/6/2022Downgrade
The Chemours Company (CC) was downgraded to B- from B on 9/6/2022 due to a substantial decline in the total return index.
The Chemours Company (CC) was downgraded to B- from B on 9/6/2022 due to a substantial decline in the total return index.
B
Buy
8/22/2022Upgraded
The Chemours Company (CC) was upgraded to B from B- on 8/22/2022 due to a substantial increase in the valuation index, total return index and growth index. Operating cash flow increased 14,450% from $2M to $291M, and total revenue increased 8.56% from $1.76B to $1.92B.
The Chemours Company (CC) was upgraded to B from B- on 8/22/2022 due to a substantial increase in the valuation index, total return index and growth index. Operating cash flow increased 14,450% from $2M to $291M, and total revenue increased 8.56% from $1.76B to $1.92B.
B
Buy
1/18/2022Upgraded
The Chemours Company (CC) was upgraded to B- from C+ on 1/18/2022 due to a major increase in the total return index.
The Chemours Company (CC) was upgraded to B- from C+ on 1/18/2022 due to a major increase in the total return index.
C
Hold
11/8/2021Upgraded
The Chemours Company (CC) was upgraded to C+ from C on 11/8/2021 due to a substantial increase in the growth index, valuation index and efficiency index. EBIT increased 314.93% from $67M to $278M, earnings per share increased from $0.39 to $1.27, and net income increased 224.24% from $66M to $214M.
The Chemours Company (CC) was upgraded to C+ from C on 11/8/2021 due to a substantial increase in the growth index, valuation index and efficiency index. EBIT increased 314.93% from $67M to $278M, earnings per share increased from $0.39 to $1.27, and net income increased 224.24% from $66M to $214M.
C
Hold
8/23/2021Downgrade
The Chemours Company (CC) was downgraded to C from C+ on 8/23/2021 due to a decline in the valuation index, total return index and dividend index.
The Chemours Company (CC) was downgraded to C from C+ on 8/23/2021 due to a decline in the valuation index, total return index and dividend index.
C
Hold
8/2/2021Upgraded
The Chemours Company (CC) was upgraded to C+ from C on 8/2/2021 due to a large increase in the total return index, volatility index and solvency index. Debt to equity declined from 4.67 to 4.41, and the quick ratio increased from 1.15 to 1.16.
The Chemours Company (CC) was upgraded to C+ from C on 8/2/2021 due to a large increase in the total return index, volatility index and solvency index. Debt to equity declined from 4.67 to 4.41, and the quick ratio increased from 1.15 to 1.16.
C
Hold
2/12/2021Upgraded
The Chemours Company (CC) was upgraded to C from C- on 2/12/2021 due to a significant increase in the valuation index, growth index and efficiency index. Operating cash flow increased 18.06% from $299M to $353M, total revenue increased 8.52% from $1.23B to $1.34B, and EBIT increased 8.06% from $124M to $134M.
The Chemours Company (CC) was upgraded to C from C- on 2/12/2021 due to a significant increase in the valuation index, growth index and efficiency index. Operating cash flow increased 18.06% from $299M to $353M, total revenue increased 8.52% from $1.23B to $1.34B, and EBIT increased 8.06% from $124M to $134M.
C
Hold
10/19/2020Upgraded
The Chemours Company (CC) was upgraded to C- from D+ on 10/19/2020 due to an increase in the total return index and volatility index.
The Chemours Company (CC) was upgraded to C- from D+ on 10/19/2020 due to an increase in the total return index and volatility index.
D
Sell
10/2/2020Downgrade
The Chemours Company (CC) was downgraded to D+ from C- on 10/2/2020 due to a decline in the volatility index.
The Chemours Company (CC) was downgraded to D+ from C- on 10/2/2020 due to a decline in the volatility index.
C
Hold
9/17/2020Upgraded
The Chemours Company (CC) was upgraded to C- from D+ on 9/17/2020 due to a large increase in the solvency index, total return index and volatility index. The quick ratio increased from 1.04 to 1.36.
The Chemours Company (CC) was upgraded to C- from D+ on 9/17/2020 due to a large increase in the solvency index, total return index and volatility index. The quick ratio increased from 1.04 to 1.36.
D
Sell
2/18/2020Downgrade
The Chemours Company (CC) was downgraded to D+ from C- on 2/18/2020 due to a significant decline in the valuation index, growth index and efficiency index. Earnings per share declined from $0.46 to -$1.9463, net income declined 517.11% from $76M to -$317M, and EBIT declined 377.93% from $145M to -$403M.
The Chemours Company (CC) was downgraded to D+ from C- on 2/18/2020 due to a significant decline in the valuation index, growth index and efficiency index. Earnings per share declined from $0.46 to -$1.9463, net income declined 517.11% from $76M to -$317M, and EBIT declined 377.93% from $145M to -$403M.
C
Hold
10/24/2019Downgrade
The Chemours Company (CC) was downgraded to C- from C on 10/24/2019 due to a decline in the volatility index and total return index.
The Chemours Company (CC) was downgraded to C- from C on 10/24/2019 due to a decline in the volatility index and total return index.
C
Hold
8/2/2019Downgrade
The Chemours Company (CC) was downgraded to C from C+ on 8/2/2019 due to a large decline in the solvency index, total return index and volatility index. Debt to equity increased from 5 to 5.13.
The Chemours Company (CC) was downgraded to C from C+ on 8/2/2019 due to a large decline in the solvency index, total return index and volatility index. Debt to equity increased from 5 to 5.13.
C
Hold
9/24/2018Downgrade
The Chemours Company (CC) was downgraded to C+ from B- on 9/24/2018 due to a major decline in the growth index, total return index and efficiency index. Net income declined 5.39% from $297M to $281M, earnings per share declined from $1.58 to $1.53, and total capital declined 3.08% from $5.16B to $5B.
The Chemours Company (CC) was downgraded to C+ from B- on 9/24/2018 due to a major decline in the growth index, total return index and efficiency index. Net income declined 5.39% from $297M to $281M, earnings per share declined from $1.58 to $1.53, and total capital declined 3.08% from $5.16B to $5B.
B
Buy
5/7/2018Upgraded
The Chemours Company (CC) was upgraded to B- from C+ on 5/7/2018 due to an increase in the growth index, valuation index and solvency index. Earnings per share increased from $1.1881 to $1.58, EBIT increased 20.65% from $310M to $374M, and debt to equity declined from 4.78 to 4.17.
The Chemours Company (CC) was upgraded to B- from C+ on 5/7/2018 due to an increase in the growth index, valuation index and solvency index. Earnings per share increased from $1.1881 to $1.58, EBIT increased 20.65% from $310M to $374M, and debt to equity declined from 4.78 to 4.17.
C
Hold
2/20/2018Upgraded
The Chemours Company (CC) was upgraded to C+ from C on 2/20/2018 due to a significant increase in the valuation index, efficiency index and solvency index. Net income increased 10.14% from $207M to $228M, debt to equity declined from 5.12 to 4.78, and total capital increased 1.57% from $4.9B to $4.98B.
The Chemours Company (CC) was upgraded to C+ from C on 2/20/2018 due to a significant increase in the valuation index, efficiency index and solvency index. Net income increased 10.14% from $207M to $228M, debt to equity declined from 5.12 to 4.78, and total capital increased 1.57% from $4.9B to $4.98B.
C
Hold
2/7/2018Downgrade
The Chemours Company (CC) was downgraded to C from C+ on 2/7/2018 due to a substantial decline in the total return index.
The Chemours Company (CC) was downgraded to C from C+ on 2/7/2018 due to a substantial decline in the total return index.
C
Hold
1/23/2018Upgraded
The Chemours Company (CC) was upgraded to C+ from C on 1/23/2018 due to a large increase in the total return index and volatility index.
The Chemours Company (CC) was upgraded to C+ from C on 1/23/2018 due to a large increase in the total return index and volatility index.
C
Hold
12/7/2017Downgrade
The Chemours Company (CC) was downgraded to C from C+ on 12/7/2017 due to a large decline in the total return index.
The Chemours Company (CC) was downgraded to C from C+ on 12/7/2017 due to a large decline in the total return index.
C
Hold
8/4/2017Upgraded
The Chemours Company (CC) was upgraded to C+ from C on 8/4/2017 due to a substantial increase in the valuation index, solvency index and efficiency index. The quick ratio increased from 1.04 to 1.43, debt to equity declined from 10.06 to 7.18, and total capital increased 18.72% from $3.91B to $4.64B.
The Chemours Company (CC) was upgraded to C+ from C on 8/4/2017 due to a substantial increase in the valuation index, solvency index and efficiency index. The quick ratio increased from 1.04 to 1.43, debt to equity declined from 10.06 to 7.18, and total capital increased 18.72% from $3.91B to $4.64B.
C
Hold
5/10/2017Upgraded
The Chemours Company (CC) was upgraded to C from C- on 5/10/2017 due to a substantial increase in the growth index, solvency index and efficiency index. Net income increased 165.22% from -$230M to $150M, earnings per share increased from -$1.2629 to $0.79, and debt to equity declined from 35.44 to 10.06.
The Chemours Company (CC) was upgraded to C from C- on 5/10/2017 due to a substantial increase in the growth index, solvency index and efficiency index. Net income increased 165.22% from -$230M to $150M, earnings per share increased from -$1.2629 to $0.79, and debt to equity declined from 35.44 to 10.06.
C
Hold
2/21/2017Downgrade
The Chemours Company (CC) was downgraded to C- from C on 2/21/2017 due to a significant decline in the valuation index, solvency index and growth index. Debt to equity increased from 9.93 to 35.44, earnings per share declined from $1.11 to -$1.2629, and EBIT declined 29.61% from $179M to $126M.
The Chemours Company (CC) was downgraded to C- from C on 2/21/2017 due to a significant decline in the valuation index, solvency index and growth index. Debt to equity increased from 9.93 to 35.44, earnings per share declined from $1.11 to -$1.2629, and EBIT declined 29.61% from $179M to $126M.
C
Hold
11/10/2016Upgraded
The Chemours Company (CC) was upgraded to C from D+ on 11/10/2016 due to a significant increase in the valuation index, growth index and solvency index. Earnings per share increased from -$0.1 to $1.11, operating cash flow increased 120% from $90M to $198M, and EBIT increased 101.12% from $89M to $179M.
The Chemours Company (CC) was upgraded to C from D+ on 11/10/2016 due to a significant increase in the valuation index, growth index and solvency index. Earnings per share increased from -$0.1 to $1.11, operating cash flow increased 120% from $90M to $198M, and EBIT increased 101.12% from $89M to $179M.
D
Sell
9/29/2016Upgraded
The Chemours Company (CC) was upgraded to D+ from D on 9/29/2016 due to an increase in the total return index, volatility index and solvency index.
The Chemours Company (CC) was upgraded to D+ from D on 9/29/2016 due to an increase in the total return index, volatility index and solvency index.
D
Sell
8/11/2016Downgrade
The Chemours Company (CC) was downgraded to D from D+ on 8/11/2016 due to a noticeable decline in the growth index and valuation index. Earnings per share declined from $0.28 to -$0.1.
The Chemours Company (CC) was downgraded to D from D+ on 8/11/2016 due to a noticeable decline in the growth index and valuation index. Earnings per share declined from $0.28 to -$0.1.
D
Sell
5/11/2016Upgraded
The Chemours Company (CC) was upgraded to D+ from D on 5/11/2016 due to a noticeable increase in the growth index, total return index and volatility index. Earnings per share increased from -$0.4849 to $0.28, and EBIT increased 48.48% from $33M to $49M.
The Chemours Company (CC) was upgraded to D+ from D on 5/11/2016 due to a noticeable increase in the growth index, total return index and volatility index. Earnings per share increased from -$0.4849 to $0.28, and EBIT increased 48.48% from $33M to $49M.
D
Sell
3/17/2016Downgrade
The Chemours Company (CC) was downgraded to D from D+ on 3/17/2016 due to a large decline in the volatility index, total return index and dividend index.
The Chemours Company (CC) was downgraded to D from D+ on 3/17/2016 due to a large decline in the volatility index, total return index and dividend index.
D
Sell
3/2/2016Upgraded
The Chemours Company (CC) was upgraded to D+ from D- on 03/02/2016.
The Chemours Company (CC) was upgraded to D+ from D- on 03/02/2016.
D
Sell
3/1/2016Upgraded
The Chemours Company (CC) was upgraded to D- from E on 03/01/2016.
The Chemours Company (CC) was upgraded to D- from E on 03/01/2016.
E
Sell
2/26/2016Downgrade
The Chemours Company (CC) was downgraded to E from E+ on 2/26/2016 due to a significant decline in the valuation index, efficiency index and total return index.
The Chemours Company (CC) was downgraded to E from E+ on 2/26/2016 due to a significant decline in the valuation index, efficiency index and total return index.
E
Sell
12/28/2015Downgrade
The Chemours Company (CC) was downgraded to E+ from D+ on 12/28/2015.
The Chemours Company (CC) was downgraded to E+ from D+ on 12/28/2015.
D
Sell
12/18/2015Upgraded
The Chemours Company (CC) was upgraded to D+ from E+ on 12/18/2015.
The Chemours Company (CC) was upgraded to D+ from E+ on 12/18/2015.
E
Sell
12/17/2015Downgrade
The Chemours Company (CC) was downgraded to E+ from D+ on 12/17/2015.
The Chemours Company (CC) was downgraded to E+ from D+ on 12/17/2015.
D
Sell
12/16/2015Upgraded
The Chemours Company (CC) was upgraded to D+ from E+ on 12/16/2015 due to an increase in the valuation index.
The Chemours Company (CC) was upgraded to D+ from E+ on 12/16/2015 due to an increase in the valuation index.
E
Sell
12/14/2015Downgrade
The Chemours Company (CC) was downgraded to E+ from D+ on 12/14/2015.
The Chemours Company (CC) was downgraded to E+ from D+ on 12/14/2015.
D
Sell
11/6/2015Downgrade
The Chemours Company (CC) was downgraded to D+ from C- on 11/6/2015 due to a decline in the solvency index, valuation index and volatility index. Debt to equity increased from 9.83 to 46.07, and the quick ratio declined from 0.88 to 0.87.
The Chemours Company (CC) was downgraded to D+ from C- on 11/6/2015 due to a decline in the solvency index, valuation index and volatility index. Debt to equity increased from 9.83 to 46.07, and the quick ratio declined from 0.88 to 0.87.
C
Hold
11/2/2015Upgraded
The Chemours Company (CC) was upgraded to C- from D+ on 11/2/2015 due to a noticeable increase in the total return index and valuation index.
The Chemours Company (CC) was upgraded to C- from D+ on 11/2/2015 due to a noticeable increase in the total return index and valuation index.
D
Sell
9/15/2015None
The Chemours Company (CC) was downgraded to D+ from U on 09/15/2015.
The Chemours Company (CC) was downgraded to D+ from U on 09/15/2015.
NYSE
03/07/2025 4:00PM Eastern
Quotes delayed
